Predictive Oncology Inc. (POAI)
USD 0.73
(-1.35%)
USD 0.73
(-1.35%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -13.92 Million USD | 8.82% |
| 2022 | -15.26 Million USD | -13.33% |
| 2021 | -13.47 Million USD | -1921.95% |
| 2020 | -666.26 Thousand USD | 95.16% |
| 2019 | -13.77 Million USD | -75.22% |
| 2018 | -7.86 Million USD | -1.48% |
| 2017 | -7.74 Million USD | -18.7% |
| 2016 | -6.52 Million USD | -48.33% |
| 2015 | -4.39 Million USD | 31.97% |
| 2014 | -6.46 Million USD | 27.55% |
| 2013 | -8.92 Million USD | -24.69% |
| 2012 | -7.15 Million USD | -74.4% |
| 2011 | -4.1 Million USD | -240.52% |
| 2010 | -1.2 Million USD | 50.66% |
| 2009 | -2.44 Million USD | -46.04% |
| 2008 | -1.67 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -3.18 Million USD | 24.72% |
| 2024 Q1 | -4.23 Million USD | -20.85% |
| 2023 Q1 | -3.46 Million USD | 21.76% |
| 2023 Q4 | -3.5 Million USD | -11.16% |
| 2023 Q3 | -3.15 Million USD | 20.34% |
| 2023 Q2 | -3.95 Million USD | -14.26% |
| 2023 FY | -13.92 Million USD | 8.82% |
| 2022 Q3 | -4.13 Million USD | -207.53% |
| 2022 Q2 | 3.84 Million USD | 212.52% |
| 2022 FY | -15.26 Million USD | -13.33% |
| 2022 Q1 | -3.41 Million USD | 60.11% |
| 2022 Q4 | -4.42 Million USD | -7.21% |
| 2021 Q3 | -5.49 Million USD | -111.43% |
| 2021 FY | -13.47 Million USD | -1921.95% |
| 2021 Q4 | -8.55 Million USD | -55.8% |
| 2021 Q2 | -2.59 Million USD | 31.22% |
| 2021 Q1 | -3.77 Million USD | 69.88% |
| 2020 Q2 | -3.76 Million USD | -9.57% |
| 2020 Q3 | -5.6 Million USD | -48.83% |
| 2020 FY | -666.26 Thousand USD | 95.16% |
| 2020 Q1 | -3.43 Million USD | -18.86% |
| 2020 Q4 | -12.54 Million USD | -123.66% |
| 2019 FY | -13.77 Million USD | -75.22% |
| 2019 Q1 | -2.33 Million USD | 17.34% |
| 2019 Q2 | -5.09 Million USD | -118.16% |
| 2019 Q3 | -3.44 Million USD | 32.44% |
| 2019 Q4 | -2.89 Million USD | 16.0% |
| 2018 FY | -7.86 Million USD | -1.48% |
| 2018 Q2 | -1.41 Million USD | 19.72% |
| 2018 Q1 | -1.76 Million USD | 38.65% |
| 2018 Q4 | -2.82 Million USD | -51.92% |
| 2018 Q3 | -1.86 Million USD | -31.72% |
| 2017 Q4 | -2.86 Million USD | -389.19% |
| 2017 FY | -7.74 Million USD | -18.7% |
| 2017 Q1 | -1.34 Million USD | -83.12% |
| 2017 Q3 | 992.09 Thousand USD | 139.0% |
| 2017 Q2 | -2.54 Million USD | -89.56% |
| 2016 Q4 | -732.77 Thousand USD | 30.58% |
| 2016 FY | -6.52 Million USD | -48.33% |
| 2016 Q3 | -1.05 Million USD | 58.79% |
| 2016 Q2 | -2.56 Million USD | -17.69% |
| 2016 Q1 | -2.17 Million USD | 3.99% |
| 2015 Q3 | -1.06 Million USD | -6.88% |
| 2015 Q2 | -996.11 Thousand USD | -1280.17% |
| 2015 Q1 | -72.17 Thousand USD | 96.65% |
| 2015 FY | -4.39 Million USD | 31.97% |
| 2015 Q4 | -2.26 Million USD | -112.92% |
| 2014 FY | -6.46 Million USD | 27.55% |
| 2014 Q4 | -2.15 Million USD | -118.92% |
| 2014 Q1 | -1.61 Million USD | -174.86% |
| 2014 Q2 | -1.72 Million USD | -6.88% |
| 2014 Q3 | -983.28 Thousand USD | 42.87% |
| 2013 Q3 | -3.63 Million USD | -224.89% |
| 2013 Q1 | -2.02 Million USD | -31.09% |
| 2013 Q4 | 2.15 Million USD | 159.22% |
| 2013 Q2 | -1.11 Million USD | 44.79% |
| 2013 FY | -8.92 Million USD | -24.69% |
| 2012 Q3 | -2.85 Million USD | -35.4% |
| 2012 Q4 | -1.54 Million USD | 45.8% |
| 2012 FY | -7.15 Million USD | -74.4% |
| 2012 Q2 | -2.1 Million USD | -219.72% |
| 2012 Q1 | -658.52 Thousand USD | 74.16% |
| 2011 Q1 | -424.26 Thousand USD | -163.49% |
| 2011 Q3 | -616.08 Thousand USD | -19.31% |
| 2011 Q4 | -2.54 Million USD | -313.68% |
| 2011 FY | -4.1 Million USD | -240.52% |
| 2011 Q2 | -516.38 Thousand USD | -21.71% |
| 2010 FY | -1.2 Million USD | 50.66% |
| 2010 Q3 | -473.11 Thousand USD | 14.14% |
| 2010 Q4 | 668.27 Thousand USD | 241.25% |
| 2010 Q2 | -551 Thousand USD | 35.16% |
| 2010 Q1 | -849.77 Thousand USD | -134.3% |
| 2009 Q4 | -362.69 Thousand USD | 55.46% |
| 2009 FY | -2.44 Million USD | -46.04% |
| 2009 Q3 | -814.27 Thousand USD | -5.4% |
| 2009 Q2 | -772.58 Thousand USD | -56.36% |
| 2009 Q1 | -494.09 Thousand USD | 32.23% |
| 2008 FY | -1.67 Million USD | 0.0% |
| 2008 Q3 | -443.4 Thousand USD | 0.0% |
| 2008 Q4 | -729.06 Thousand USD | -64.43% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -57.66 Million USD | 75.86% |
| AngioDynamics, Inc. | -97.71 Million USD | 85.754% |
| AtriCure, Inc. | -26.68 Million USD | 47.827% |
| Avinger, Inc. | -16.63 Million USD | 16.313% |
| Azenta, Inc. | -73.12 Million USD | 80.963% |
| BioLife Solutions, Inc. | -70.82 Million USD | 80.344% |
| The Cooper Companies, Inc. | 533.1 Million USD | 102.611% |
| Daxor Corporation | -177.07 Thousand USD | -7761.826% |
| Ekso Bionics Holdings, Inc. | -15.11 Million USD | 7.879% |
| Femasys Inc. | -14.5 Million USD | 4.047% |
| GlucoTrack, Inc. | -7.1 Million USD | -95.965% |
| Harvard Bioscience, Inc. | 1.89 Million USD | 835.023% |
| Hologic, Inc. | 882.6 Million USD | 101.577% |
| ICU Medical, Inc. | 22.82 Million USD | 160.992% |
| Intuitive Surgical, Inc. | 1.76 Billion USD | 100.788% |
| KORU Medical Systems, Inc. | -10.26 Million USD | -35.554% |
| LeMaitre Vascular, Inc. | 37.08 Million USD | 137.542% |
| Innovative Eyewear, Inc. | -6.9 Million USD | -101.743% |
| Innovative Eyewear, Inc. | -6.9 Million USD | -101.743% |
| Masimo Corporation | 136.5 Million USD | 110.199% |
| Microbot Medical Inc. | -9.85 Million USD | -41.262% |
| Meihua International Medical Technologies Co., Ltd. | 14.67 Million USD | 194.865% |
| Merit Medical Systems, Inc. | 123.94 Million USD | 111.232% |
| Nephros, Inc. | -1.59 Million USD | -773.906% |
| NovoCure Limited | -232.87 Million USD | 94.022% |
| NEXGEL, Inc. | -3.47 Million USD | -300.383% |
| NEXGEL, Inc. | -3.47 Million USD | -300.383% |
| Singular Genomics Systems, Inc. | -102.8 Million USD | 86.458% |
| OraSure Technologies, Inc. | 54.07 Million USD | 125.743% |
| Pro-Dex, Inc. | 7.17 Million USD | 294.08% |
| Pulse Biosciences, Inc. | -43.57 Million USD | 68.051% |
| Precision Optics Corporation, Inc. | -2.72 Million USD | -410.999% |
| QuidelOrtho Corporation | 139.1 Million USD | 110.008% |
| Repligen Corporation | 54.57 Million USD | 125.508% |
| Sanara MedTech Inc. | -4.21 Million USD | -230.269% |
| STAAR Surgical Company | 28.09 Million USD | 149.547% |
| Sharps Technology, Inc. | -10.12 Million USD | -37.472% |
| Utah Medical Products, Inc. | 16.77 Million USD | 182.979% |
| DENTSPLY SIRONA Inc. | -85 Million USD | 83.622% |
| Jin Medical International Ltd. | 2.86 Million USD | 585.527% |